Metastatic Hepatocellular Carcinoma Recruiting Phase 2 Trials for Atezolizumab (DB11595)

Also known as: Hepatocellular Carcinoma Metastatic / Metastatic hepatocellular carcinoma (disorder) / Metastatic hepatocellular carcinoma (morphologic abnormality) / Liver cell carcinoma / Primary liver cell carcinoma (disorder) / Hepatocellular carcinoma / Carcinoma hepatocellular / Hepatoma / Primary carcinoma of liver (disorder) / Liver carcinoma / Carcinoma liver / Liver cell carcinoma (disorder) / Hepatocellular carcinoma (morphologic abnormality) / Carcinoma of liver / Carcinoma, Hepatocellular

IndicationStatusPhase
DBCOND0041971 (Metastatic Hepatocellular Carcinoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05168163Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver CancerTreatment